Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. ResApp Health Limited
  6. Company
    RAP   AU000000RAP5

RESAPP HEALTH LIMITED

(RAP)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
ResApp Health Limited is engaged in developing digital healthcare solutions to assist doctors and patients to diagnose and manage respiratory disease. The Company offers a range of solutions, such as telehealth, clinical use, direct consumer and big data insights. The Company provides point of care diagnostic solutions for telehealth companies, which is integrated into their platforms. The Company is working on applications to provide clinical quality diagnostic tests and management tools directly to consumers and healthcare providers. The Company is developing smartphone medical applications for the diagnosis and management of respiratory disease. The Company's technology is based on the premise that cough and breathing sounds carry vital information on the state of the respiratory tract. ResApp measures the severity of a range of chronic and acute diseases, such as pneumonia, asthma, bronchiolitis and chronic obstructive pulmonary disease (COPD) using this insight.
Managers
Name Title Age Since
Tony Keating, Dr. Chief Executive Officer, Executive Director & MD - 2015
Udantha Abeyratne Chief Scientist - -
Rob Keniger Vice President-Technology - -
Roger Aston, Dr. Non-Executive Chairman 64 2015
Brian Leedman Vice President-Corporate Affairs - 2017
Nicki Farley Secretary 41 2021
Jamie Joint Director-Sales & Marketing - -
Margaret Kay Taylor Vice President-Emerging Markets 60 -
Mike Connell Vice President-Commercial - 2021
Members of the board
Name Title Age Since
Roger Aston, Dr. Non-Executive Chairman 64 2015
Christopher Ntoumenopoulos Non-Executive Director - 2015
Tony Keating, Dr. Chief Executive Officer, Executive Director & MD - 2015
Michael Stein, Dr. Non-Executive Director 56 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 758,119,489 725,351,114 95.7% 0 0.0% 95.7%
Shareholders
NameEquities%
FIL Investment Management (Hong Kong) Ltd. 85,783,372 9.98%
FIL Investment Management (Australia) Ltd. 4,063,174 0.47%
BetaShares Capital Ltd. 941,236 0.11%
FIL Ltd. 50,415 0.0059%
Sector Enterprise Software
1st jan.Capi. (M$)
RESAPP HEALTH LIMITED-51.76%26
ORACLE CORPORATION34.77%245 138
SAP SE12.83%165 850
INTUIT INC.37.66%142 890
SERVICENOW, INC.5.98%114 972
DOCUSIGN, INC.37.12%58 848
CONSTELLATION SOFTWARE INC.16.83%32 573
HUBSPOT, INC.47.78%27 375
RINGCENTRAL, INC.-29.70%23 871
PAYCOM SOFTWARE, INC.-14.08%22 456
TRIMBLE INC.25.98%20 702
YONYOU NETWORK TECHNOLOGY CO., LTD.-16.96%18 228
SANGFOR TECHNOLOGIES INC.-0.61%16 151
XERO LIMITED-5.24%15 429
FAIR ISAAC CORPORATION3.21%15 246
CERIDIAN HCM HOLDING INC.-7.48%14 542
OPEN TEXT CORPORATION13.90%13 928
SHANGHAI BAOSIGHT SOFTWARE CO.,LTD.28.45%12 529
GLODON COMPANY LIMITED-21.93%11 831
LIGHTSPEED POS INC.22.86%11 750
PEGASYSTEMS INC.2.72%10 889